How to Register a Medical Device in India Under CDSCO: 2026 Step-by-Step Guide

 

CDSCO medical device registration is the common term used across the industry, but Indian law does not issue a single, universal "registration certificate" for all devices. Under the Medical Devices Rules, 2017 (MDR 2017), approval requires obtaining specific manufacturing or import licences or registration numbers depending on the device's risk classification (Class A, B, C, or D), whether it is manufactured domestically or imported, its intended purpose, and whether it is a sterile or measuring unit.

How Does CDSCO Medical Device Registration Work?

1. Verify Medical Device Status: Confirm your product meets the legal definition under Rule 3(z) of MDR 2017.

2. Identify Risk Classification: Determine if the device is Class A (low), Class B (low-moderate), Class C (moderate-high), or Class D (high risk) using official CDSCO classification lists.

3. Establish Legal Persona: Determine if you are an Indian Manufacturer or an Indian Importer / Indian Authorised Agent (IAA) representing a foreign manufacturer.

4. Identify the Licensing Authority: Apply to the State Licensing Authority (SLA) for domestic Class A/B manufacturing, or the Central Licensing Authority (CLA) for domestic Class C/D manufacturing, all imports, test licences, and novel devices.

5. Select the Correct Regulatory Form: Match your pathway to the right application form (e.g., MD-3, MD-7, MD-12, or MD-14).

6. Compile Technical Dossier & QMS: Prepare your Plant Master File (PMF), Device Master File (DMF), ISO 13485 QMS certification, testing reports, and risk management documentation.

7. Submit via Online Portals: File applications digitally using the CDSCO Medical Devices portal or the SUGAM portal.

8. Undergo Scrutiny & Audit: Pay government fees, clear desktop technical evaluation, and undergo site inspection/audit where mandatory.

9. Secure Approval & Maintain Compliance: Receive your licence (e.g., MD-5, MD-6, MD-9, MD-10, MD-15) and maintain 5-year retention fee cycles alongside post-market surveillance obligations.

What Is CDSCO Medical Device Registration?

The Central Drugs Standard Control Organization (CDSCO), headed by the Drugs Controller General of India (DCGI) under the Ministry of Health and Family Welfare (MoHFW), acts as India’s National Regulatory Authority (NRA).

Prior to 2017, medical devices were regulated under generic provisions of the Drugs and Cosmetics Act, 1940. The introduction of the Medical Devices Rules, 2017 (MDR 2017) created a distinct, risk-based framework aligned with Global Harmonization Task Force (GHTF) principles.

"CDSCO registration" is an umbrella term covering several distinct regulatory instruments:

• System Registration Numbers: Simplified online filing for Class A Non-Sterile, Non-Measuring (NSNM) devices.

• Manufacturing Licences: State-issued (Class A/B) or Center-issued (Class C/D) permissions to produce devices inside India.

• Import Licences: Central-issued permissions to bring foreign-made medical devices into India.

• Test Licences & Clinical Permissions: Specialized authorisations to import/manufacture small batches for testing, evaluation, or clinical investigation.

Who Needs CDSCO Approval or Licensing?

Under MDR 2017, any commercial entity placing a regulated medical device on the Indian market must hold valid approval:

• Indian Domestic Manufacturers: Must obtain manufacturing licences or registration numbers before commercial production.

• Foreign Manufacturers: Cannot apply directly to CDSCO. They must appoint a legally designated Indian Authorised Agent (IAA) holding a valid wholesale drug licence.

• Importers: Must hold an import licence (e.g., Form MD-15) issued to their appointed Indian Authorised Agent or licensed import facility.

• Distributors, Stockists, and Retailers: Must hold applicable state wholesale/retail drug sales licences (Form 20B/21B) and adhere to medical device storage/distribution provisions.

Is Your Product a Medical Device?

Before filing an application, verify that your product falls within the statutory scope of Rule 3(z) of MDR 2017. A product is a medical device if it is an instrument, apparatus, appliance, software, material, or other article used alone or in combination—including software intended by its manufacturer to be used specifically for diagnostic or therapeutic purposes—and does not achieve its primary intended action in or on the human body by pharmacological, immunological, or metabolic means.

Medical Device Classification in India

India classifies medical devices into four risk tiers under Rule 4 of MDR 2017:

Risk Class	Risk Level	Example Medical Devices	Example In-Vitro Diagnostics (IVD)
Class A	Low Risk	Non-sterile examination gloves, tongue depressors, surgical masks.	General ELISAs, general culture media, manual staining solutions.
Class B	Low-to-Moderate Risk	Hypodermic needles, suction pumps, blood pressure monitors, oxygen concentrators.	Blood glucose monitors, pregnancy test kits.
Class C	Moderate-to-High Risk	Hemodialysis catheters, surgical lasers, bone screws, x-ray equipment.	Hepatitis B/C diagnostic kits, PSA screening assays.
Class D	High Risk	Coronary stents, pacemakers, heart valves, implantable defibrillators.	HIV diagnostic assays, blood grouping reagents.

Regulatory Impact of Classification

Your device classification determines:

• Jurisdiction: CLA (Central) vs. SLA (State).

• Audit & Quality Management: Mandatory prior audit before licence grant (Class C/D) vs. post-grant audit options (Class A/B).

• Evaluation Scrutiny: Mandatory evaluation by Subject Expert Committees (SEC) for novel technology or Class C/D devices.

• Testing Requirements: Extent of local or accredited testing required before filing.

CDSCO Medical Device Licence and Form Matrix

Navigating CDSCO requires mapping your exact commercial role and device risk class to the correct application and licence forms:

Scenario / Pathway	Application Form	Issued Licence / Outcome	Licensing Authority	Key Statutory Notes
Class A Non-Sterile & Non-Measuring (NSNM) Manufacture or Import	Online Registration	Registration Number	Central Licensing Authority	Exempt from standard licensing; governed by Chapter IIIB (G.S.R. 777(E)).
Class A (Sterile/Measuring) & Class B Domestic Manufacturing	Form MD-3	Form MD-5	State Licensing Authority (SLA)	Audit conducted within 120 days post-licence grant for Class A; prior audit for Class B.
Class C & Class D Domestic Manufacturing	Form MD-7	Form MD-9	Central Licensing Authority (CLA)	Mandatory pre-licensing audit by CDSCO Medical Device Officers / notified bodies.
Loan Licence Domestic Class A / B	Form MD-4	Form MD-6	State Licensing Authority (SLA)	Applied by entities using another manufacturer's licensed facility.
Loan Licence Domestic Class C / D	Form MD-8	Form MD-10	Central Licensing Authority (CLA)	Applied by entities using another manufacturer's licensed facility.
Test Licence Domestic Manufacturing	Form MD-12	Form MD-13	State or Central Authority	For manufacturing small batches for testing, evaluation, or clinical investigation.
Import Licence (All Classes A, B, C, D)	Form MD-14	Form MD-15	Central Licensing Authority (CLA)	Filed by Indian Authorised Agent; covers foreign manufacturing sites and products.
Test Licence for Import	Form MD-16	Form MD-17	Central Licensing Authority (CLA)	For importing small quantities for testing, evaluation, or clinical studies.
Clinical Investigation Permission	Form MD-22	Form MD-23	Central Licensing Authority (CLA)	Permission to conduct clinical trial of investigational medical device in India.
Import / Manufacture of Unclassified / Novel Devices	Form MD-26	Form MD-27	Central Licensing Authority (CLA)	Required for devices without predicate or official classification in India.

CDSCO Registration Process for Indian Manufacturers

Step 1: Confirm Classification & Central Listing

Verify that your device is listed in the official CDSCO medical device classification spreadsheet. Under recent CDSCO directives, if a device is unclassified, you must first apply to the Central Licensing Authority (CLA) for central classification verification before applying to an SLA.

• Failure point: Applying to an SLA for an unclassified device leads to licence rejection or invalidation.

Step 2: Quality Management System (QMS) Setup

Implement a QMS compliant with the Fifth Schedule of MDR 2017 (aligned with ISO 13485:2016). Prepare the Plant Master File (PMF) and standard operating procedures (SOPs).

Step 3: Obtain Test Licence (Form MD-13)

Apply on Form MD-12 to obtain a Test Licence (Form MD-13). This allows you to legally manufacture test batches for laboratory testing and performance evaluation.

Step 4: Product Testing & Evaluation

Send test batch samples to CDSCO-notified testing laboratories to verify compliance with essential principles and relevant standards (IS/ISO/IEC).

Step 5: Technical Dossier Compilation

Assemble the Device Master File (DMF) including biocompatibility, shelf-life, risk management, software validation, and draft labelling/IFU.

Step 6: Submit Licence Application

• Class A/B: File Form MD-3 via the online portal to the SLA.

• Class C/D: File Form MD-7 via the SUGAM portal to the CLA.

Step 7: Audit & Scrutiny

• Class A/B: SLA carries out desktop scrutiny; audit takes place post-grant (Class A) or pre-grant (Class B).

• Class C/D: Joint inspection team (Central & State Medical Device Officers) audits the manufacturing site pre-licensing.

Step 8: Licence Grant & Post-Market Setup

Upon resolving all queries and clearing audit observations, Form MD-5 or Form MD-9 is granted. Establish post-market surveillance (PMS) and adverse event reporting protocols.

CDSCO Registration Process for Foreign Manufacturers and Importers

Foreign manufacturers cannot submit applications directly to CDSCO. They must operate through an Indian Authorised Agent (IAA).

Essential Steps for Foreign Manufacturers:

1. Appoint an Indian Authorised Agent (IAA): The IAA must be an Indian legal entity holding a valid wholesale drug/device sales licence (Form 20B/21B).

2. Execute Power of Attorney (PoA): A legally binding Power of Attorney executed by the foreign manufacturer, authorizing the IAA to act on their behalf before CDSCO. It must be authenticated via Apostille or consular legalization.

3. Obtain Free Sale Certificate (FSC): Secure an FSC or Marketing Authorization from the National Regulatory Authority (NRA) of the country of origin or recognized reference countries (USA, EU, UK, Japan, Australia, Canada).

4. Compile Import Technical Dossier: The overseas facility must supply the Plant Master File (PMF), Device Master File (DMF), ISO 13485 certificate, shelf-life data, biocompatibility reports, and clinical evaluation data.

5. File Form MD-14 via SUGAM: The IAA submits the import application online under Form MD-14, attaching all required dossier sections and paying prescribed government fees.

6. Regulatory Scrutiny & Query Handling: CDSCO reviews the application. Higher-risk or novel devices may be referred to a Subject Expert Committee (SEC). The IAA and foreign manufacturer must address technical queries within the stipulated timeframe.

7. Issuance of Form MD-15: Once cleared, CDSCO issues the Import Licence on Form MD-15.

Documents Required for CDSCO Medical Device Registration

The required documentation depends on the device classification, pathway, and manufacturing origin.

Document Category	Document Name	Domestic (MD-3 / MD-7)	Foreign / Importer (MD-14)
Administrative	Wholesale Licence (Form 20B/21B)	Optional / Contextual	Mandatory (For IAA/Importer)
Administrative	Power of Attorney (Authenticated)	Not Applicable	Mandatory
Administrative	Free Sale Certificate (Country of Origin)	Not Applicable	Mandatory
QMS & Site	ISO 13485:2016 Certificate	Mandatory	Mandatory
QMS & Site	Plant Master File (PMF)	Mandatory	Mandatory
Technical	Device Master File (DMF)	Mandatory (Class B, C, D)	Mandatory
Testing	Product Performance Test Reports	Mandatory	Mandatory
Testing	Biocompatibility & Sterilization Data	Mandatory (where applicable)	Mandatory (where applicable)
Clinical	Clinical Evaluation / Performance Study Data	Mandatory (Class C, D & Novel)	Mandatory (Class C, D & Novel)
Labelling	Draft Labels & Instructions for Use (IFU)	Mandatory	Mandatory

Medical Device Technical Documentation

A technical submission to CDSCO relies on two comprehensive core files:

1. Plant Master File (PMF)

Describes the manufacturing environment and quality system:

• General facility layout, cleanroom classifications, and environmental controls.

• Production processes, equipment validation, and utility systems (water, HVAC).

• Quality assurance, supplier qualification, and sanitation management.

2. Device Master File (DMF)

Contains technical data specific to the device model:

• Device Description & Specification: Intended use, indications, principles of operation, and product variants.

• Risk Management File: Risk analysis executed per ISO 14971 standards.

• Design Verification & Validation: Electrical safety (IEC 60601-1), software lifecycle (IEC 62304), biocompatibility (ISO 10993), and bench testing.

• Sterilization Validation: Ethylene Oxide (EtO), Gamma, or Steam sterilization validation reports (including site details).

• Shelf-Life & Stability Studies: Accelerated and real-time stability testing data supporting claimed shelf life.

• Clinical Evidence: Clinical evaluation report (CER) demonstrating safety and performance.

CDSCO Medical Device Testing and Evaluation

Testing validates product safety and efficacy prior to commercial release:

• Government & Accredited Testing: Samples manufactured under a Test Licence (MD-13) or imported under an Import Test Licence (MD-17) must undergo testing at CDSCO-notified laboratories or NABL-accredited labs.

• In-Vitro Diagnostics (IVD) Performance Evaluation: IVDs must undergo performance evaluation at designated central laboratories (such as NIB Noida for blood-grouping/HIV, or specified national institutes).

• Waiving Local Testing: Foreign product testing data is evaluated by CDSCO; if testing was conducted using international standard methods (e.g., ISO/IEC) in ISO 17025 accredited labs, local re-testing can often be waived for standard non-IVD devices.

How to Apply Through the CDSCO Online/SUGAM System

Applications are submitted digitally via official CDSCO portals:

1. Portal Registration: Register an enterprise account on the SUGAM Portal (cdscosugam.gov.in) or the specialized Medical Device portal.

2. Profile Authorization: Upload organizational documents (PAN, Incorporation Certificate, Wholesale Licence, ID proofs) and submit for portal profile verification.

3. Form Selection: Select the target application form (e.g., MD-3, MD-7, MD-14) from the dashboard.

4. Data Entry: Enter product details, generic name, brand name, model numbers, intended use, and site addresses.

5. Dossier Upload: Attach PDFs of the PMF, DMF, ISO certificates, testing reports, labels, and PoA into designated upload slots.

6. Fee Payment: Pay government fees electronically via Bharatkosh integrated payment gateway.

7. Query Tracking & Response: Monitor the application dashboard for regulatory queries (Deficiency Letters). Submit clarifications and supplementary documentation directly within the portal.

How Much Does CDSCO Medical Device Registration Cost?

Total expenditure includes statutory fees alongside operational preparation costs:

Statutory CDSCO Government Fees (Indication Framework under MDR 2017)

• Class A / B Manufacturing Licence (MD-3): ₹5,000 per manufacturing site + ₹500 per distinct device model.

• Class C / D Manufacturing Licence (MD-7): ₹50,000 per manufacturing site + ₹1,000 per distinct device model.

• Import Licence (MD-14):

• Class A: ~$1,000 per site + ~$50 per device variant.

• Class B: ~$2,000 per site + ~$1,000 per device variant.

• Class C / D: ~$3,000 to ~$3,500 per site + ~$1,500 per device variant.

Key Operational Cost Drivers

• Testing & Laboratory Fees: Varies by test complexity (electrical safety, EMC, biocompatibility, sterility).

• QMS Implementation & Audit Fees: Notified Body audit costs for Class A/B or Class C/D manufacturing site audits.

• Consular Legalization / Apostille: Fees for authenticating overseas Free Sale Certificates and Power of Attorney documents.

• Regulatory Consulting & Authorized Agent Services: Professional fees for technical dossier preparation and Indian Authorised Agent representation.

How Long Does CDSCO Registration Take?

Official processing times set by regulation differ from total practical lead times:

Application Type	Official Timeline (MDR 2017 Target)	Practical Planning Range	Primary Timeline Drivers
Class A NSNM Registration	Immediate / Automated	1 to 7 Days	Document readiness and portal uptime.
Class A/B Domestic Manufacturing	60–90 Days	3 to 6 Months	Test Licence acquisition, laboratory testing duration, SLA audit scheduling.
Class C/D Domestic Manufacturing	120–180 Days	6 to 9 Months	Joint audit coordination, SEC expert review, complex technical dossier validation.
Import Licence (Class A/B)	90 Days	3 to 5 Months	Dossier completeness, authentication of foreign documents, query response speed.
Import Licence (Class C/D)	90–120 Days	5 to 9 Months	Subject Expert Committee (SEC) review cycles, clinical evidence validation.

Important CDSCO Medical Device Regulatory Updates in 2026

Regulatory oversight in India continues to evolve. Key developments include:

1. Mandatory Central Classification Prior to Licensing: Under CDSCO directives, Central Licensing Authority (CLA) classification verification is mandatory before any State Licensing Authority (SLA) can issue manufacturing licences. SLAs cannot issue licences for unlisted devices.

2. Draft MDR 2026 Amendments & Sterilization Traceability: Proposed regulatory changes introduce explicit statutory definitions for the Certificate of Registration and mandate that the sterilization site licence number be printed on the sterile medical device label to ensure supply-chain traceability.

3. Class A NSNM Registration System (Chapter IIIB): Registration for Class A Non-Sterile, Non-Measuring devices under G.S.R. 777(E) is managed through a self-certification framework, subject to post-market surveillance audits.

4. Dynamic Category Reclassifications: CDSCO continuously updates its risk classification lists across categories such as software as a medical device (SaMD), operation theatre systems, renal care, and personal protective equipment. Reclassified devices must align their licensing with their updated risk category.

What Happens After CDSCO Licence/Approval?

Obtaining a licence initiates ongoing compliance requirements:

• Perpetual Validity & 5-Year Retention: Licences issued under MDR 2017 remain valid indefinitely provided the holder pays the prescribed retention fee every 5 years prior to completion of the 5-year period.

• Post-Market Surveillance (PMS): Licence holders must track post-market performance, document customer complaints, and maintain sales distribution records.

• Materiavigilance Program of India (MvPI): Mandatory reporting of Serious Adverse Events (SAE) involving medical devices to CDSCO within regulatory timelines (15 days for severe incidents).

• Change Control Oversight:

• Major Changes: (e.g., change in manufacturing site, raw material, or design affecting safety/performance) Requires prior approval from the licensing authority via formal amendment.

• Minor Changes: (e.g., minor packaging or administrative updates) Requires notification to the authority within 30 days.

Common Reasons CDSCO Applications Are Delayed or Queried

Application Mistake	Root Cause	Prevention & Action Tip
Incorrect Device Classification	Relying on outdated spreadsheets or self-assigning lower risk classes.	Verify the device against current CDSCO classification lists; apply to CLA for formal classification if unlisted.
Wrong Regulatory Form Selection	Confusing manufacturing forms (MD-3/7) or import forms (MD-14/16).	Use the Form Matrix above to map your commercial activity correctly before filing.
Inconsistent Intended Use	IFU, label, and DMF state conflicting clinical indications.	Ensure identical wording for intended use across the application, testing reports, FSC, and labels.
Foreign Document Deficiencies	Power of Attorney or FSC lacking Apostille/consular authentication.	Complete full legal authentication (Apostille/consular seal) before submission.
Gaps in Testing Standards	Testing conducted per outdated standards or in non-accredited laboratories.	Verify that testing labs hold valid ISO/IEC 17025 accreditation covering the specific standard test methods.
Incomplete Query Responses	Submitting partial explanations without supporting technical data.	Provide complete documentary evidence for every item raised in a Deficiency Letter.

CDSCO Medical Device Pre-Application Checklist

Use this operational checklist before submitting your CDSCO application:

• Device Identification: Intended use, target user, patient population, and medical claims clearly documented.

• Classification Verification: Device risk category verified against the latest CDSCO online database.

• Pathway & Form Selected: Confirmed proper form pathway (MD-3, MD-7, MD-14, etc.).

• Legal Representation: Valid Wholesale Licence held by Importer/IAA; Apostilled Power of Attorney executed.

• Quality System: Valid ISO 13485 certificate and Plant Master File (PMF) available.

• Technical Dossier Complete: Device Master File (DMF), risk management file, and stability data compiled.

• Testing Reports Validated: Safety, performance, and biocompatibility test reports available from accredited labs.

• Labelling Compliance: Draft artwork and IFU comply with Rule 84 of MDR 2017.

• SUGAM Portal Account Active: Enterprise profile verified and administrative details updated.

Domestic Manufacturer vs Foreign Manufacturer

Dimension	Domestic Indian Manufacturer	Foreign Manufacturer (Import Route)
Applicant Persona	Indian Manufacturing Enterprise.	Indian Authorised Agent (IAA) holding wholesale licence.
Primary Forms	Form MD-3 (Class A/B) or Form MD-7 (Class C/D).	Form MD-14 (All Device Classes).
Target Licence	Form MD-5 (Class A/B) or Form MD-9 (Class C/D).	Form MD-15 Import Licence.
Licensing Jurisdiction	SLA for Class A/B; CLA for Class C/D.	Central Licensing Authority (CLA) exclusively.
Site Audit	Inspection of local physical plant by Medical Device Officers.	Foreign site audit by CDSCO or desktop review of ISO 13485 & overseas audit reports.
Core Documentation	PMF, DMF, local test batch reports via MD-13.	PMF, DMF, Free Sale Certificate, Apostilled Power of Attorney.
Local Testing	Batch testing under Test Licence mandatory.	May leverage international testing data if accredited.

Frequently Asked Questions

Is CDSCO registration mandatory for medical devices in India?

Yes. Commercialization, manufacture, import, sale, or distribution of medical devices in India requires compliance with the Medical Devices Rules, 2017, through a licence, registration, or regulatory approval.

What is the difference between CDSCO registration and a medical device licence?

"Registration" generally refers to simplified self-certification pathways for low-risk Class A Non-Sterile/Non-Measuring devices under Chapter IIIB. A "Licence" (e.g., MD-5, MD-9, MD-15) is a formal regulatory approval issued by state or central authorities following technical dossier review and site audits.

What are Class A, B, C, and D medical devices?

They represent the four risk tiers under MDR 2017: Class A (low risk), Class B (low-to-moderate risk), Class C (moderate-to-high risk), and Class D (high risk).

What is Form MD-14 used for?

Form MD-14 is the official application form submitted by an Indian Authorised Agent to apply for a licence (Form MD-15) to import medical devices into India.

What is the difference between MD-14 and MD-16?

Form MD-14 is used to apply for a commercial import licence (MD-15). Form MD-16 is used to apply for a test licence (MD-17) to import small quantities of medical devices solely for testing, evaluation, or clinical trials.

Which forms are used for domestic medical device manufacturing?

Domestic manufacturers use Form MD-3 to apply for a Class A/B licence (MD-5) from the State authority, and Form MD-7 to apply for a Class C/D licence (MD-9) from the Central authority.

Does a foreign manufacturer need an Indian Authorised Agent?

Yes. Foreign manufacturers cannot apply directly to CDSCO. They must appoint an Indian Authorised Agent (IAA) residing in India who holds a valid wholesale drug/device licence.

What documents are required for CDSCO approval?

Primary requirements include the Plant Master File (PMF), Device Master File (DMF), ISO 13485 certification, product test reports, risk management files, labeling/IFU, and—for imports—a Free Sale Certificate and authenticated Power of Attorney.

How much does CDSCO registration cost?

Government application fees range from ₹5,000 for local low-risk manufacturing sites up to ~$3,500 for foreign Class C/D manufacturing sites, plus additional per-device fees. Total investment also includes testing, auditing, and dossier compilation costs.

How long does CDSCO approval take?

Timelines range from 1 to 7 days for Class A NSNM online registrations up to 5 to 9 months for complex Class C/D import or manufacturing approvals requiring technical review and committee evaluations.

What happens after the licence is granted?

Licences remain valid perpetually provided retention fees are paid every 5 years. Licence holders must maintain quality management systems, execute post-market surveillance, report adverse events, and manage change controls.

Where can I verify current CDSCO requirements?

Official requirements, classification lists, circulars, and gazette notifications can be verified directly on the official CDSCO portal (cdsco.gov.in) and the CDSCO SUGAM portal (cdscosugam.gov.in).

Navigating CDSCO Compliance with Confidence

Understanding the regulatory pathway for your medical device is critical to avoiding costly delays, product seizures, or application rejections. Whether establishing domestic manufacturing under Form MD-3/MD-7 or coordinating overseas import representation under Form MD-14, ensuring dossier accuracy and procedural alignment remains paramount.

If your team requires expert guidance on risk classification, technical dossier assembly, ISO 13485 audit readiness, or Indian Authorised Agent representation, seek qualified regulatory strategy support to ensure seamless market entry into India.